ENTRY       D04048                      Drug
NAME        Ropivacaine hydrochloride (USP);
            Ropivacaine hydrochloride hydrate (JAN);
            Anapeine (TN)
PRODUCT     NAROPIN (Fresenius Kabi USA)
            NAROPIN (Fresenius Kabi USA)
            NAROPIN (Fresenius Kabi USA)
            NAROPIN (Fresenius Kabi USA)
            NAROPIN (General Injectables & Vaccines)
            NAROPIN (Henry Schein)
  GENERIC   ROPIVACAINE HYDROCHLORIDE (Akorn)
            ROPIVACAINE HYDROCHLORIDE (Akorn)
            ROPIVACAINE HYDROCHLORIDE (Amneal Pharmaceuticals LLC)
            ROPIVACAINE HYDROCHLORIDE (Baxter Healthcare Corporation)
            ROPIVACAINE HYDROCHLORIDE (Caplin Steriles Limited)
            ROPIVACAINE HYDROCHLORIDE (Civica)
            ROPIVACAINE HYDROCHLORIDE (Eugia US LLC)
            ROPIVACAINE HYDROCHLORIDE (Gland Pharma Limited)
            ROPIVACAINE HYDROCHLORIDE (Hikma Pharmaceuticals USA)
            ROPIVACAINE HYDROCHLORIDE (Hospira)
            ROPIVACAINE HYDROCHLORIDE (Sagent Pharmaceuticals)
            ROPIVACAINE HYDROCHLORIDE (Sagent Pharmaceuticals)
            ROPIVACAINE HYDROCHLORIDE (Somerset Therapeutics)
FORMULA     C17H26N2O. HCl. H2O
EXACT_MASS  328.1918
MOL_WEIGHT  328.8774
CLASS       Neuropsychiatric agent
             DG02030  Anesthetics
              DG01675  Local anesthetic
               DG01673  Amide type local anesthetic
            Metabolizing enzyme substrate
             DG01892  CYP1A2 substrate
             DG01633  CYP3A/CYP3A4 substrate
              DG02913  CYP3A4 substrate
REMARK      Therapeutic category: 1214
            ATC code: N01BB09
            Chemical structure group: DG00806
            Product (DG00806): D04048<JP/US>
EFFICACY    Anesthetic (local)
TARGET      SCN1A [HSA:6323] [KO:K04833]
            SCN2A [HSA:6326] [KO:K04834]
            SCN3A [HSA:6328] [KO:K04836]
            SCN4A [HSA:6329] [KO:K04837]
            SCN5A [HSA:6331] [KO:K04838]
            SCN8A [HSA:6334] [KO:K04840]
            SCN9A [HSA:6335] [KO:K04841]
            SCN10A [HSA:6336] [KO:K04842]
            SCN11A [HSA:11280] [KO:K04843]
  PATHWAY   hsa04728(6323)  Dopaminergic synapse
METABOLISM  Enzyme: CYP1A2 [HSA:1544], CYP3A4 [HSA:1576]
INTERACTION  
STR_MAP     map07231  Sodium channel blocking drugs
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             N NERVOUS SYSTEM
              N01 ANESTHETICS
               N01B ANESTHETICS, LOCAL
                N01BB Amides
                 N01BB09 Ropivacaine
                  D04048  Ropivacaine hydrochloride (USP) &lt;JP/US&gt;
            Therapeutic category of drugs in Japan [BR:br08301]
             1  Agents affecting nervous system and sensory organs
              12  Agents affecting peripheral nervous system
               121  Local anesthetics
                1214  Xylidines
                 D04048  Ropivacaine hydrochloride (USP); Ropivacaine hydrochloride hydrate (JAN)
            Drug groups [BR:br08330]
             Neuropsychiatric agent
              DG02030  Anesthetics
               DG01675  Local anesthetic
                DG01673  Amide type local anesthetic
                 DG00806  Ropivacaine
                  D04048  Ropivacaine hydrochloride
             Metabolizing enzyme substrate
              DG01892  CYP1A2 substrate
               DG00806  Ropivacaine
                D04048  Ropivacaine hydrochloride
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                DG00806  Ropivacaine
                 D04048  Ropivacaine hydrochloride
            Target-based classification of drugs [BR:br08310]
             Ion channels
              Voltage-gated ion channels
               Sodium channels
                SCN1A
                 D04048  Ropivacaine hydrochloride (USP) &lt;JP/US&gt;
                SCN2A
                 D04048  Ropivacaine hydrochloride (USP) &lt;JP/US&gt;
                SCN3A
                 D04048  Ropivacaine hydrochloride (USP) &lt;JP/US&gt;
                SCN4A
                 D04048  Ropivacaine hydrochloride (USP) &lt;JP/US&gt;
                SCN5A
                 D04048  Ropivacaine hydrochloride (USP) &lt;JP/US&gt;
                SCN8A
                 D04048  Ropivacaine hydrochloride (USP) &lt;JP/US&gt;
                SCN9A
                 D04048  Ropivacaine hydrochloride (USP) &lt;JP/US&gt;
                SCN10A
                 D04048  Ropivacaine hydrochloride (USP) &lt;JP/US&gt;
                SCN11A
                 D04048  Ropivacaine hydrochloride (USP) &lt;JP/US&gt;
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D04048
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D04048
            Drug groups [BR:br08330]
             Neuropsychiatric agent
              DG02030  Anesthetics
               DG01675  Local anesthetic
                DG01673  Amide type local anesthetic
                 DG00806  Ropivacaine
             Metabolizing enzyme substrate
              DG01892  CYP1A2 substrate
               DG00806  Ropivacaine
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                DG00806  Ropivacaine
DBLINKS     CAS: 132112-35-7
            PubChem: 47206010
            ChEBI: 34954
            LigandBox: D04048
            NIKKAJI: J2.220.367C
ATOM        22
            1   X   Cl   31.2200  -18.2001
            2   O0  O    31.7800  -21.0001
            3   C8x C    20.8600  -18.3400
            4   C8x C    20.8600  -19.7400
            5   C8y C    22.0500  -20.4400
            6   C8y C    23.3100  -19.7400
            7   C8y C    23.3100  -18.3400
            8   C8x C    22.0500  -17.6400
            9   N1b N    24.5000  -20.4400
            10  C5a C    25.6900  -19.7400
            11  C1a C    24.5000  -17.6400
            12  C1y C    26.9500  -20.4400
            13  N1y N    26.9500  -21.8400
            14  C1x C    28.1400  -22.5400
            15  C1x C    29.3300  -21.8400
            16  C1x C    29.3300  -20.4400
            17  C1x C    28.1400  -19.7400
            18  C1a C    22.0500  -21.8400
            19  C1b C    25.6900  -22.5400
            20  C1b C    24.5000  -21.8400
            21  C1a C    23.3100  -22.5400
            22  O5a O    25.6900  -18.3400
BOND        21
            1     3   4 2
            2     4   5 1
            3     5   6 2
            4     6   7 1
            5     7   8 2
            6     3   8 1
            7     6   9 1
            8     9  10 1
            9     7  11 1
            10   12  10 1 #Down
            11   12  13 1
            12   13  14 1
            13   14  15 1
            14   15  16 1
            15   16  17 1
            16   12  17 1
            17    5  18 1
            18   13  19 1
            19   19  20 1
            20   20  21 1
            21   10  22 2
///
